Edition:
India

Apollo Endosurgery Inc (APEN.OQ)

APEN.OQ on NASDAQ Stock Exchange Global Market

6.61USD
1:30am IST
Change (% chg)

$-0.01 (-0.15%)
Prev Close
$6.62
Open
$6.56
Day's High
$6.73
Day's Low
$6.46
Volume
9,051
Avg. Vol
8,745
52-wk High
$8.25
52-wk Low
$3.60

Chart for

About

Apollo Endosurgery, Inc., formerly Lpath, Inc., is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company's device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80... (more)

Overall

Beta: 0.47
Market Cap(Mil.): $94.37
Shares Outstanding(Mil.): 17.25
Dividend: --
Yield (%): --

Financials

BRIEF-Apollo Endosurgery Q4 Loss Per Share $0.42

* APOLLO ENDOSURGERY, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

02 Mar 2018

BRIEF-Apollo Endosurgery Announces MFDS Approval For Orbera Intragastric Balloon System

* APOLLO ENDOSURGERY ANNOUNCES MFDS APPROVAL FOR ORBERA INTRAGASTRIC BALLOON SYSTEM IN SOUTH KOREA, A NON-SURGICAL SOLUTION TO ASSIST PATIENTS WITH WEIGHT LOSS Source text for Eikon: Further company coverage:

23 Feb 2018

Earnings vs. Estimates